Figure 1: Proposed algorithm for the screening of potential anticancer drugs against human brain tumors to decide whether to engage (GO) or not (no-GO) into early (Phase I and II) clinical trials. The algorithm is composed of seven Steps 1–7 where decisions can be made. See main text for details.